Anti‐tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Anti‐tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma

Published:2020-07-31 Issue:1 Volume:252 Page:65-76
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Leung Ming‐Sum¹,Chan Kristy Kwan‐Shuen¹,Dai Wen‐Juan¹,Wong Cheuk‐Yan¹,Au Kwan‐Yung¹,Wong Pik‐Ying¹,Wong Carmen Chak‐Lui¹²^ORCID,Lee Terence Kin‐Wah³^ORCID,Ng Irene Oi‐Lin¹²^ORCID,Kao Weiyuan John⁴,Lo Regina Cheuk‐Lam¹²^ORCID

Affiliation:

1. Department of Pathology The University of Hong Kong Hong Kong SAR PR China

2. State Key Laboratory of Liver Research (The University of Hong Kong) Hong Kong SAR PR China

3. Department of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Hong Kong SAR PR China

4. Department of Industrial and Manufacturing Systems Engineering, Biomedical Engineering Program of Faculty of Engineering and LKS Faculty of Medicine The University of Hong Kong Hong Kong SAR PR China

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5492

Reference48 articles.

1. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma

2. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway

3. Why target PIM1 for cancer diagnosis and treatment?

4. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis

5. PIM Kinase as an Executional Target in Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles;Journal of Medicinal Chemistry;2024-01-02

2. Design, synthesis, biological evaluation and molecular docking study of new pyrazolo[1,5-a]pyrimidines as PIM kinase inhibitors and apoptosis inducers;Journal of Molecular Structure;2024-01

3. Cyanopyridinone- and Cyanopyridine-Based Cancer Cell Pim-1 Inhibitors: Design, Synthesis, Radiolabeling, Biodistribution, and Molecular Modeling Simulation;ACS Omega;2023-05-24

4. Use of Apatinib as a Bait to Fish its Unexpected Kinase Targets from the Hepatocellular Carcinoma Druggable Kinome;Journal of Computational Biophysics and Chemistry;2023-02-20

5. ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma;Cancer Letters;2023-02